iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI)

Assessment and management of MCI.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
NeurologyGeriatricsMental Health

Clinical Guidelines

Differential diagnosis | Diagnosis | Dementia | CKS | NICE
National
NICE - Dementia | Health topics A to Z | CKS
National

Recent iatroX Q&As

  • What are the key diagnostic criteria for identifying Mild Cognitive Impairment (MCI) in primary care settings?Updated: 8/22/2025
  • How can I differentiate between MCI and early-stage dementia during patient assessments?Updated: 8/22/2025
  • What non-pharmacological interventions are recommended for managing patients diagnosed with MCI?Updated: 8/22/2025
  • When should I consider referring a patient with MCI to a specialist for further evaluation?Updated: 8/22/2025
  • What role do cognitive screening tools play in the assessment of MCI in a general practice setting?Updated: 8/22/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play